IN2014DN08385A - - Google Patents

Info

Publication number
IN2014DN08385A
IN2014DN08385A IN8385DEN2014A IN2014DN08385A IN 2014DN08385 A IN2014DN08385 A IN 2014DN08385A IN 8385DEN2014 A IN8385DEN2014 A IN 8385DEN2014A IN 2014DN08385 A IN2014DN08385 A IN 2014DN08385A
Authority
IN
India
Prior art keywords
antithrombin
pre eclampsia
atryn
treatment
disclosure provides
Prior art date
Application number
Inventor
Johan Frieling
Simon Lowry
Original Assignee
Lfb Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lfb Usa Inc filed Critical Lfb Usa Inc
Publication of IN2014DN08385A publication Critical patent/IN2014DN08385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In one aspect the disclosure provides methods for the treatment of pre eclampsia and severe pre eclampsia comprising administering antithrombin. In some embodiments the antithrombin used in the methods disclosed herein is ATryn®.
IN8385DEN2014 2012-03-12 2013-03-12 IN2014DN08385A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261609534P 2012-03-12 2012-03-12
PCT/US2013/030350 WO2013138271A1 (en) 2012-03-12 2013-03-12 The use of antithrombin in the treatment of pre-eclampsia

Publications (1)

Publication Number Publication Date
IN2014DN08385A true IN2014DN08385A (en) 2015-05-08

Family

ID=49161701

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8385DEN2014 IN2014DN08385A (en) 2012-03-12 2013-03-12

Country Status (12)

Country Link
US (1) US20140206617A1 (en)
EP (1) EP2825194A4 (en)
JP (1) JP2015509984A (en)
KR (1) KR20140135219A (en)
CN (1) CN104321076A (en)
AR (1) AR090315A1 (en)
AU (1) AU2013203512B2 (en)
CA (1) CA2871159A1 (en)
IN (1) IN2014DN08385A (en)
MX (1) MX2014010940A (en)
TW (1) TW201400499A (en)
WO (1) WO2013138271A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2811526T3 (en) 2010-12-30 2021-03-12 Lab Francais Du Fractionnement Glycols as pathogen inactivating agents
MX2015001508A (en) 2012-08-03 2015-04-08 Lfb Usa Inc The use of antithrombin in extracorporeal membrane oxygenation.
US10174110B2 (en) 2013-02-13 2019-01-08 Laboratoire Français Du Fractionnement Et Des Biotechnologies Highly galactosylated anti-TNF-α antibodies and uses thereof
AR094778A1 (en) 2013-02-13 2015-08-26 Laboratoire Français Du Fractionnement Et Des Biotechnologies PROTEINS WITH MODIFIED GLYCOSILATION AND METHODS FOR PRODUCERS
CN105358228A (en) 2013-07-05 2016-02-24 法国血液分割暨生化制品实验室 Affinity chromatography matrix
FR3038517B1 (en) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies USE OF MODIFIED FC FRAGMENTS IN IMMUNOTHERAPY
WO2021073518A1 (en) * 2019-10-17 2021-04-22 中国科学院动物研究所 Use of inhibitor of plasmin inhibitory factor for preventing or treating pre-eclampsia or eclampsia
CN113406326B (en) * 2021-06-01 2022-08-26 大连医科大学 Biological marker for predicting preeclampsia and application thereof
CN118593717A (en) * 2024-05-31 2024-09-06 厦门特宝生物工程股份有限公司 A pharmaceutical composition for treating and/or preventing preeclampsia and its application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751873T2 (en) 1986-04-09 1997-02-13 Genzyme Corp Genetically transformed animals that secrete a desired protein in milk
WO1992016192A1 (en) 1991-03-15 1992-10-01 Amgen Inc. Pulmonary administration of granulocyte colony stimulating factor
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5843705A (en) 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
US20050271660A1 (en) * 2002-09-06 2005-12-08 Alexion Pharmaceuticals, Inc. Nebulization of monoclonal antibodies for treating pulmonary diseases
CA2572179A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
CA2598528A1 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material
US20070037192A1 (en) * 2005-07-25 2007-02-15 Gtc Biotherapeutics, Inc. Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
US7521632B2 (en) 2006-08-31 2009-04-21 Gaton Corporation Door hinge assembly and enclosure employing the same

Also Published As

Publication number Publication date
JP2015509984A (en) 2015-04-02
CA2871159A1 (en) 2013-09-19
KR20140135219A (en) 2014-11-25
AU2013203512B2 (en) 2016-02-25
AU2013203512A1 (en) 2013-09-26
AR090315A1 (en) 2014-11-05
WO2013138271A1 (en) 2013-09-19
MX2014010940A (en) 2015-04-13
CN104321076A (en) 2015-01-28
US20140206617A1 (en) 2014-07-24
EP2825194A1 (en) 2015-01-21
TW201400499A (en) 2014-01-01
EP2825194A4 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
IN2014DN08385A (en)
ZA202208792B (en) Methods of treating and preventing graft versus host disease
HK1220980A1 (en) Methods and compositions for treatment of pompe disease
UA118248C2 (en) Glucosylceramide synthase inhibitors
TW201611843A (en) Methods of treatment with arginine deiminase
IN2015DN01156A (en)
MX2020010535A (en) Methods of treating cancer.
MX369691B (en) Glutamase inhibitors and method of use.
MX356525B (en) Aav -vectors for use in gene therapy of choroideremia.
MX370573B (en) Gla monotherapy for use in cancer treatment.
PH12014500075A1 (en) Pharmaceutical composition, methods for treating and uses thereof
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
MX2015012502A (en) Dna-pk inhibitors.
WO2012092336A3 (en) Molecular profiling for cancer
AU2011328009A8 (en) Compounds and methods for treating pain
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
PH12013502487A1 (en) Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
MX349886B (en) Anti-pseudomonas psl binding molecules and uses thereof.
NZ628433A (en) Chitosan-derived compositions
IN2014CN04634A (en)
MX359181B (en) Collagen hydrolysate and use thereof.
UA112760C2 (en) THEOBROMIN IN COMBINATION WITH GUYPHENESINE FOR THE TREATMENT OF Cough
MX2015001648A (en) Compositions comprising spicamycin derivatives and methods of use thereof.
EP3449917A3 (en) Tapentadol for preventing chronification of pain
AU2010298020A8 (en) Combination